Parikh RB - Search Results

1

Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate Cancer.

Lin JK, Hearn CM, Getzen E, Long Q, Lee DC, Keaveny TM, Jayadevappa R, Robinson KW, Wong YN, Maxwell KN, Narayan V, Haas NB, Takvorian SU, Bikle DD, Chiang JM, Khan AN, Rajapakse CS, Morgans AK, Parikh RB. Lin JK, et al. Among authors: parikh rb. Eur Urol Oncol. 2023 Nov 3:S2588-9311(23)00230-4. doi: 10.1016/j.euo.2023.10.016. Online ahead of print. Eur Urol Oncol. 2023. PMID: 37926618

2

Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer.

Jayadevappa R, Chhatre S, Malkowicz SB, Parikh RB, Guzzo T, Wein AJ. Jayadevappa R, et al. Among authors: parikh rb. JAMA Netw Open. 2019 Jul 3;2(7):e196562. doi: 10.1001/jamanetworkopen.2019.6562. JAMA Netw Open. 2019. PMID: 31268539 Free PMC article.

3

Effectiveness of First-line Immune Checkpoint Blockade Versus Carboplatin-based Chemotherapy for Metastatic Urothelial Cancer.

Feld E, Harton J, Meropol NJ, Adamson BJS, Cohen A, Parikh RB, Galsky MD, Narayan V, Christodouleas J, Vaughn DJ, Hubbard RA, Mamtani R. Feld E, et al. Among authors: parikh rb. Eur Urol. 2019 Oct;76(4):524-532. doi: 10.1016/j.eururo.2019.07.032. Epub 2019 Jul 28. Eur Urol. 2019. PMID: 31362898 Free PMC article.

4

Validation of a Machine Learning Algorithm to Predict 180-Day Mortality for Outpatients With Cancer.

Manz CR, Chen J, Liu M, Chivers C, Regli SH, Braun J, Draugelis M, Hanson CW, Shulman LN, Schuchter LM, O'Connor N, Bekelman JE, Patel MS, Parikh RB. Manz CR, et al. Among authors: parikh rb. JAMA Oncol. 2020 Nov 1;6(11):1723-1730. doi: 10.1001/jamaoncol.2020.4331. JAMA Oncol. 2020. PMID: 32970131 Free PMC article.

5

Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.

Parikh RB, Robinson KW, Chhatre S, Medvedeva E, Cashy JP, Veera S, Bauml JM, Fojo T, Navathe AS, Malkowicz SB, Mamtani R, Jayadevappa R. Parikh RB, et al. JAMA Netw Open. 2020 Sep 1;3(9):e2018318. doi: 10.1001/jamanetworkopen.2020.18318. JAMA Netw Open. 2020. PMID: 32986109 Free PMC article.

6

Assessment and Management of Cardiovascular Risk Factors Among US Veterans With Prostate Cancer.

Sun L, Parikh RB, Hubbard RA, Cashy J, Takvorian SU, Vaughn DJ, Robinson KW, Narayan V, Ky B. Sun L, et al. Among authors: parikh rb. JAMA Netw Open. 2021 Feb 1;4(2):e210070. doi: 10.1001/jamanetworkopen.2021.0070. JAMA Netw Open. 2021. PMID: 33625512 Free PMC article.

7

Long-term depression incidence and associated mortality among African American and White prostate cancer survivors.

Parikh RB, Gallo JJ, Wong YN, Robinson KW, Cashy JP, Narayan V, Jayadevappa R, Chhatre S. Parikh RB, et al. Cancer. 2021 Sep 15;127(18):3476-3485. doi: 10.1002/cncr.33656. Epub 2021 Jun 1. Cancer. 2021. PMID: 34061986 Free article.

8

Behavioral economic implementation strategies to improve serious illness communication between clinicians and high-risk patients with cancer: protocol for a cluster randomized pragmatic trial.

Takvorian SU, Bekelman J, Beidas RS, Schnoll R, Clifton ABW, Salam T, Gabriel P, Wileyto EP, Scott CA, Asch DA, Buttenheim AM, Rendle KA, Chaiyachati K, Shelton RC, Ware S, Chivers C, Schuchter LM, Kumar P, Shulman LN, O'Connor N, Lieberman A, Zentgraf K, Parikh RB. Takvorian SU, et al. Among authors: parikh rb. Implement Sci. 2021 Sep 25;16(1):90. doi: 10.1186/s13012-021-01156-6. Implement Sci. 2021. PMID: 34563227 Free PMC article.

9

Impact of the COVID-19 pandemic on treatment patterns for US patients with metastatic solid cancer.

Parikh RB, Takvorian SU, Vader D, Wileyto EP, Clark AS, Lee DJ, Goyal G, Rocque GB, Dotan E, Geynisman DM, Phull P, Spiess PE, Kim RY, Davidoff AJ, Gross CP, Neparidze N, Miksad RA, Calip GS, Hearn CM, Ferrell W, Shulman LN, Mamtani R, Hubbard RA; PRACTICE Investigators. Parikh RB, et al. medRxiv [Preprint]. 2021 Sep 23:2021.09.22.21263964. doi: 10.1101/2021.09.22.21263964. medRxiv. 2021. PMID: 34611665 Free PMC article. Updated. Preprint.

10

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy Among Trial-Ineligible Patients With Advanced Solid Cancers.

Parikh RB, Min EJ, Wileyto EP, Riaz F, Gross CP, Cohen RB, Hubbard RA, Long Q, Mamtani R. Parikh RB, et al. JAMA Oncol. 2021 Dec 1;7(12):1843-1850. doi: 10.1001/jamaoncol.2021.4971. JAMA Oncol. 2021. PMID: 34734979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page